1. (40 pts. total) An article in JAMA by Mandelblatt et al (2002) compared the societal costs and benefits of human papillomavirus (HPV) testing, Pap testing, and their combination to screen for cervical cancer. The following table summarizes some of the results (low cost to high cost). Costs include screening and treatment costs, discounted over the individual's expected lifetime. Strategy Cost ($) QALYS Saved Incremental Cost Incremental QALY Incremental CE ratio (ICER) 0. No screening 5,000 26.87 6,825 27.02 6,950 27.02 7,275 27.04 1. Pap every 3 years to age 75 2. HPV every 3 years to age 75 3. Pap every 2 years to age 75 4. Pap + HPV every 3 years to age 75 5. HPV every 2 years to age 75 6. Pap + HPV every 2 years to age 75 7,400 27.04 7,450 27.04 7,925 27.05 a. (6 pts.) Identify all dominated screening strategies. Recall a strategy is dominated if it costs more than an equally or more effective strategy, or it is less effective than another strategy that costs the same or less. List the strategy number(s) here. b. (30 pts.) Fill in the table above. Calculate the incremental cost, incremental QALYS, and ICERs for all economically rational strategies (relative to strategy O, no screening). C. (4 pts.) The local health district has asked your opinion on the "best" strategy from a public health perspective. What do you tell them